926 related articles for article (PubMed ID: 19604278)
1. The importance of strain variation in virulence of Candida dubliniensis and Candida albicans: results of a blinded histopathological study of invasive candidiasis.
Asmundsdóttir LR; Erlendsdóttir H; Agnarsson BA; Gottfredsson M
Clin Microbiol Infect; 2009 Jun; 15(6):576-85. PubMed ID: 19604278
[TBL] [Abstract][Full Text] [Related]
2. Lower filamentation rates of Candida dubliniensis contribute to its lower virulence in comparison with Candida albicans.
Stokes C; Moran GP; Spiering MJ; Cole GT; Coleman DC; Sullivan DJ
Fungal Genet Biol; 2007 Sep; 44(9):920-31. PubMed ID: 17251042
[TBL] [Abstract][Full Text] [Related]
3. Differential regulation of the transcriptional repressor NRG1 accounts for altered host-cell interactions in Candida albicans and Candida dubliniensis.
Moran GP; MacCallum DM; Spiering MJ; Coleman DC; Sullivan DJ
Mol Microbiol; 2007 Nov; 66(4):915-29. PubMed ID: 17927699
[TBL] [Abstract][Full Text] [Related]
4. Quantitative evaluation of tissue invasion by wild type, hyphal and SAP mutants of Candida albicans, and non-albicans Candida species in reconstituted human oral epithelium.
Jayatilake JA; Samaranayake YH; Cheung LK; Samaranayake LP
J Oral Pathol Med; 2006 Sep; 35(8):484-91. PubMed ID: 16918600
[TBL] [Abstract][Full Text] [Related]
5. Experimental systemic virulence of oral Candida dubliniensis isolates in comparison with Candida albicans, Candida tropicalis and Candida krusei.
Koga-Ito CY; Komiyama EY; Martins CA; Vasconcellos TC; Jorge AO; Carvalho YR; do Prado RF; Balducci I
Mycoses; 2011 Sep; 54(5):e278-85. PubMed ID: 20492535
[TBL] [Abstract][Full Text] [Related]
6. Candida dubliniensis, a new fungal pathogen.
Gutiérrez J; Morales P; González MA; Quindós G
J Basic Microbiol; 2002; 42(3):207-27. PubMed ID: 12111748
[TBL] [Abstract][Full Text] [Related]
7. Experimental pathogenicity of Candida albicans and Candida dubliniensis with continuous and discontinuous fringes morphotypes.
de Vasconcellos TC; Komiyama EY; Jorge AO; Brighenti FL; Vidotto V; Koga-Ito CY
Mycoses; 2011 Jul; 54(4):e163-7. PubMed ID: 20337935
[TBL] [Abstract][Full Text] [Related]
8. Candida albicans strain-dependent virulence and Rim13p-mediated filamentation in experimental keratomycosis.
Mitchell BM; Wu TG; Jackson BE; Wilhelmus KR
Invest Ophthalmol Vis Sci; 2007 Feb; 48(2):774-80. PubMed ID: 17251477
[TBL] [Abstract][Full Text] [Related]
9. Systemic infection following intravenous inoculation of mice with Candida albicans int1 mutant strains.
Bendel CM; Kinneberg KM; Jechorek RP; Gale CA; Erlandsen SL; Hostetter MK; Wells CL
Mol Genet Metab; 1999 Aug; 67(4):343-51. PubMed ID: 10444345
[TBL] [Abstract][Full Text] [Related]
10. Variation in biofilm formation among blood and oral isolates of Candida albicans and Candida dubliniensis.
Villar-Vidal M; Marcos-Arias C; Eraso E; Quindós G
Enferm Infecc Microbiol Clin; 2011 Nov; 29(9):660-5. PubMed ID: 21899928
[TBL] [Abstract][Full Text] [Related]
11. Candida dubliniensis: ten years on.
Sullivan DJ; Moran GP; Coleman DC
FEMS Microbiol Lett; 2005 Dec; 253(1):9-17. PubMed ID: 16213674
[TBL] [Abstract][Full Text] [Related]
12. Comparison of phospholipase and proteinase activity in Candida albicans and C. dubliniensis.
Fotedar R; Al-Hedaithy SS
Mycoses; 2005 Jan; 48(1):62-7. PubMed ID: 15679669
[TBL] [Abstract][Full Text] [Related]
13. Candidaemia with uncommon Candida species: predisposing factors, outcome, antifungal susceptibility, and implications for management.
Chen SC; Marriott D; Playford EG; Nguyen Q; Ellis D; Meyer W; Sorrell TC; Slavin M;
Clin Microbiol Infect; 2009 Jul; 15(7):662-9. PubMed ID: 19614718
[TBL] [Abstract][Full Text] [Related]
14. Differentiation of Candida dubliniensis on chrom agar and Pal's agar.
Raut SH; Varaiya A
Indian J Med Microbiol; 2009; 27(1):55-8. PubMed ID: 19172062
[TBL] [Abstract][Full Text] [Related]
15. [Molecular identification of Candida albicans and Candida dubliniensis strains isolated from clinical samples].
Toraman ZA; Bulut Y; Yilmaz M; Ozdarendeli A
Mikrobiyol Bul; 2005 Apr; 39(2):199-204. PubMed ID: 16128031
[TBL] [Abstract][Full Text] [Related]
16. Drosophila melanogaster as a facile model for large-scale studies of virulence mechanisms and antifungal drug efficacy in Candida species.
Chamilos G; Lionakis MS; Lewis RE; Lopez-Ribot JL; Saville SP; Albert ND; Halder G; Kontoyiannis DP
J Infect Dis; 2006 Apr; 193(7):1014-22. PubMed ID: 16518764
[TBL] [Abstract][Full Text] [Related]
17. In vivo pathogenicity of eight medically relevant Candida species in an animal model.
Arendrup M; Horn T; Frimodt-Møller N
Infection; 2002 Oct; 30(5):286-91. PubMed ID: 12382088
[TBL] [Abstract][Full Text] [Related]
18. Variation of cell surface hydrophobicity and biofilm formation among genotypes of Candida albicans and Candida dubliniensis under antifungal treatment.
Borecká-Melkusová S; Bujdáková H
Can J Microbiol; 2008 Sep; 54(9):718-24. PubMed ID: 18772934
[TBL] [Abstract][Full Text] [Related]
19. The involvement of physico-chemical interactions in the adhesion of Candida albicans and Candida dubliniensis to epithelial cells.
Henriques M; Azeredo J; Oliveira R
Mycoses; 2007 Sep; 50(5):391-6. PubMed ID: 17714359
[TBL] [Abstract][Full Text] [Related]
20. Candida dubliniensis: an emerging opportunistic pathogen.
Sullivan D; Coleman D
Curr Top Med Mycol; 1997 Dec; 8(1-2):15-25. PubMed ID: 9504063
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
